Wegovy may cut cardiovascular risk
The maker of diabetes and weight loss medication Wegovy said a trial found that the drug can also cut the risk of cardiovascular disease by 20%.
Weight Loss
Study: Wegovy cuts heart attack, stroke risk
A new study shows the popular weight loss drug Wegovy can also reduce the risk of a heart attack or stroke by 20%. That's according to a not yet peer-reviewed clinical trial performed by drugmaker Novo Nordisk that studied more than 17,000 non-diabetic adults with heart disease who were obese or overweight. Cardiologist Dr. Ernst von Schwarz joins CBS News to discuss the significance of the findings.
Ozempic, Mounjaro makers sued over "stomach paralysis" claims
A personal injury law firm filed a suit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro.
Weight loss drug makers facing lawsuit
The makers of Ozempic and Mounjaro, drugs used for both weight loss and diabetes management, are facing a lawsuit claiming the medications can cause "stomach paralysis." Janet Shamlian reports.
Weight loss drugs and mental health
The European Medicines Agency is broadening its investigation into a class of popular weight loss and diabetes drugs after patients in Iceland reported thoughts of self-harm and suicide after taking Ozempic and Saxenda. Dr. Celine Gounder. editor-at-large for public health at KFF Health News and a CBS News medical contributor, has more.
Ozempic side effects could lead to hospitalization; long-term impacts unknown
Shedding pounds isn't the only change patients might experience.
The safety and promise of new weight loss drugs
The drug used in Ozempic, Wegovy and other groundbreaking medications could soon be available in pill form if the FDA approves. Dr. Celine Gounder, a CBS News medical contributor and editor-at-large for public health at KFF Health News, has more on how these drugs work and how safe they are.
Ozempic, Wegovy may soon be available in pill form
Ozempic and Wegovy, the injectable diabetes medications that are also being used for weight loss, may soon be available in pill form. Drugmaker Novo Nordisk said it will seek approval for the pills later this year.
What to know about berberine, the trending weight loss supplement
Berberine is the latest supplement craze, gaining attention on social media as a "natural" weight loss option. Here's what to know, according to experts.
FDA issues warning about weight loss drugs
The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency "received adverse event reports after patients used compounded semaglutide." That's the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.
Are you taking part in "ambition sizing"? Here's how to judge
Ambition sizing is drastic weight loss tied to a specific event - and it can be more harmful than you think. Here's why.
Jenny Craig plans to close its weight-loss centers, report says
Employees are losing their jobs as weight-loss company's plans to wind down its brick-and-mortar business.
Eli Lilly seeks FDA approval for weight loss drug
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.
Social media fuels enthusiasm for new weight loss drugs
The new medications show promise for inducing weight loss, but many aren't FDA-approved for that use.
Ozempic-like drug Wegovy coming to the U.K. at a fraction of U.S. price
The maker of semaglutide tells CBS News it has ramped up production "24-hours, seven days a week" to meet expected demand in new markets.
Half of world will be overweight or obese by 2035, report finds
The report from the World Obesity Federation also predicts childhood obesity could more than double compared to 2020 levels.
Weight loss drugs rise in popularity
CBS News medical contributor Dr. Celine Gounder joins "CBS Mornings" to discuss the rising popularity of weight loss drugs, who is eligible and the costs.
New guidelines for treating childhood obesity
New recommendations to treat childhood obesity from the American Academy of Pediatrics now include considering weight loss medications and surgery. It's the first update in 15 years. Dr. Dyan Hes, founder and medical director of Gramercy Pediatrics, joins CBS News discuss the risks and benefits.
A medication for obesity
Lesley Stahl reports on how obesity is misunderstood, and the struggle to get new weight loss drugs to people who need them.
Doctors explain how Wegovy and Ozempic work
The semaglutide injections have grown in popularity as a mechanism to help with weight loss for type 2 diabetes and obesity diagnoses.
Mindfulness helped Kathy Bates lose 60 pounds
The 70-year-old actress said she learned about mindfulness from her niece – and has never felt better
Trump says he'll start paying for ads after pushback over taxpayer funding
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump suggests letting Iran "take out" LA, San Diego during rally
Rubio calls on Russia to be more open about plague lab worker's death
Live
Iran's Houthi allies deny losing ground as Mideast crisis engulfs Yemen
Ex-"American Idol" contestant Caleb Flynn gets life sentence
Alleged Chinese agent makes federal court appearance
Only On CBS
Takeaways from Alito's CBS News interview
